About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Oncologist
›
Top Articles
Oncologist
Oncology
5.7
(top 2%)
Impact Factor
6.2
(top 2%)
extended IF
180
(top 1%)
H-Index
3.7K
authors
5.2K
papers
189.9K
citations
8.3K
citing journals
93.3K
citing authors
Most Cited Articles of Oncologist
Title
Year
Citations
SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer
2000
1.6K
FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma
2007
975
Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition
2000
894
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine
2009
838
Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program
2007
743
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective
2010
691
Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib
2004
681
Management of cancer in the older person: a practical approach
2000
675
The role of ABC transporters in clinical practice
2003
619
The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies
2009
591
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
2013
580
Cancer-related fatigue: the scale of the problem
2007
575
The role of hypoxia-induced factors in tumor progression
2004
568
Photodynamic therapy in oncology
2006
544
Triple-negative breast cancer: an unmet medical need
2011
542
Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping
2012
532
Biology and therapeutic advances for pediatric osteosarcoma
2004
527
TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility
2006
510
Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response
2004
508
Obesity and cancer
2010
496
The clinical approach towards chondrosarcoma
2008
488
Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy
2003
481
Beyond costs and benefits: understanding how patients make health care decisions
2010
476
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
2018
464
Vascular endothelial growth factor as a target for anticancer therapy
2004
462
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.